Joy Olbertz

Joy Olbertz has extensive experience in the pharmaceutical industry, particularly in rare disease drug development. Joy has worked at multiple companies and held various leadership roles. At Intellia Therapeutics, Inc., they currently serve as the Senior Director, Clinical Scientist. Prior to this, they worked at Global Blood Therapeutics as a Medical Director. Joy spent a significant portion of their career at BioMarin Pharmaceutical Inc., where they served as a Senior Director. Joy'sresponsibilities at BioMarin included leading drug development, overseeing clinical studies, filing regulatory documents, and serving as a global clinical lead. Before joining BioMarin, Joy worked at Celerion, where they held roles such as Senior Director, Cardiac Safety Services, Clinical Site Director, Director of Cardiac Safety Services, and Clinical Research Pharmacist. In these roles, they led strategic planning, business development initiatives, financial oversight, and operational management. Joy also developed professional relationships with key opinion leaders in cardiac safety. Overall, Joy Olbertz has a strong background in drug development, clinical research, and leadership.

Joy Olbertz obtained a Doctor of Pharmacy (PharmD) degree in pharmacology from Idaho State University. Additionally, Joy holds certifications as a pharmacist from both the Arizona State Board of Pharmacy and the Idaho State Board of Pharmacy.